Evaluate the Effect of Tirazamine on Primary Liver Cancer.

NCT06848556 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Company Operational Strategy Adjustment

Conditions

Hepato Cellular Carcinoma (HCC)

Interventions

DRUG: tirapazamine
PROCEDURE: Transarterial Embolization
PROCEDURE: TACE

Sponsor

Zhejiang Raygene Pharmaceuticals Co., Ltd